Wobenzym in therapy of
various forms of fibrocystic disease with individually selected
immunomodulators.
Loginova N.S., Naumkina N.G., Sukhikh
G.T. Wobenzym in therapy of various forms of fibrocystic disease
with individually selected immunomodulators. International congress
"Advances in Immunology and Allergology at the Treshold of the XXI
Century" May 3-6, 2000, Eilat, Israel. Czech abstract
Cancer of mammary glands is known to be registered 3-5 times more
often in patients with fibrocystic disease (FCD), the risk increases
30 times as much in the signs of proliferation. We elaborated
therapy regimen for patients with FCD by means of Wobenzym having
antiinflammatory, immunomodulating effect. Immunomodulators were
selected individually for every patient under the control of
interferon status (IFS): Cycloferon, Ridostin, Polyoxidony. The
treatment was performed in 36 women, aged from 23 to 52, having
various forms of FCD: diffuse FCD: 1. multiple large filled cysts,
1.5-5.5 cm in diameter; 2. small cystic component prevailing; 3.
glandular component prevailing. To assess the dynamic control of the
quality of the therapy, we used radiothermometric method based on
the measurement of internal temperature area (focal thermoassymetry).